用于急性白血病的蛋白激酶抑制剂
Protein kinase inhibitors for acute leukemia.
作者信息
Ling Yuan, Xie Qing, Zhang Zikang, Zhang Hua
机构信息
Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Institute of Laboratory Medicine, Guangdong Medical University, Dongguan, 523808 China.
出版信息
Biomark Res. 2018 Feb 13;6:8. doi: 10.1186/s40364-018-0123-1. eCollection 2018.
Abstract
Conventional treatments for acute leukemia include chemotherapy, radiation therapy, and intensive combined treatments (including bone marrow transplant or stem cell transplants). Novel treatment approaches are in active development. Recently, protein kinase inhibitors are on clinical trials and offer hope as new drugs for acute leukemia treatment. This review will provide a brief summary of the protein kinase inhibitors in clinical applications for acute leukemia treatment.
摘要
急性白血病的传统治疗方法包括化疗、放疗以及强化联合治疗（包括骨髓移植或干细胞移植）。新型治疗方法正在积极研发中。最近，蛋白激酶抑制剂正在进行临床试验，并有望成为治疗急性白血病的新药。本综述将简要总结蛋白激酶抑制剂在急性白血病治疗临床应用中的情况。
相似文献
1
Protein kinase inhibitors for acute leukemia.
Biomark Res. 2018 Feb 13;6:8. doi: 10.1186/s40364-018-0123-1. eCollection 2018.
2
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges.
Curr Pharm Des. 2017 Nov 16;23(29):4303-4310. doi: 10.2174/1381612823666170703164114.
3
4
Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
Semin Hematol. 1987 Jan;24(1):55-67.
5
MDM2- and FLT3-inhibitors in the treatment of -ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin.
Haematologica. 2018 Nov;103(11):1862-1872. doi: 10.3324/haematol.2018.191650. Epub 2018 Jul 5.
6
Current and emerging therapies for acute myeloid leukemia.
Clin Ther. 2009;31 Pt 2:2349-70. doi: 10.1016/j.clinthera.2009.11.017.
7
Autologous bone marrow transplantation for leukemia.
Semin Oncol. 1993 Oct;20(5 Suppl 6):40-54.
8
[New Drugs in the Treatment of Acute Myeloid Leukemia in the Elderly].
Klin Onkol. 2017 Summer;30(3):190-196. doi: 10.14735/amko2017190.
9
Inhibition of raf kinase in the treatment of acute myeloid leukemia.
Curr Pharm Des. 2002;8(25):2243-8. doi: 10.2174/1381612023393008.
10
Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. A report from the International Bone Marrow Transplant Registry.
Am J Pediatr Hematol Oncol. 1993 Feb;15(1):56-64. doi: 10.1097/00043426-199302000-00006.
引用本文的文献
1
One step further in targeting acute leukemia by combining antibody-based immunotherapies and small molecule inhibitors.
Cancer Cell Int. 2025 Jul 7;25(1):254. doi: 10.1186/s12935-025-03869-w.
2
Impact of aging on acute myeloid leukemia epidemiology and survival outcomes: A real-world, population-based longitudinal cohort study.
PLoS One. 2024 May 21;19(5):e0300637. doi: 10.1371/journal.pone.0300637. eCollection 2024.
3
Kinase Inhibitors in Genetic Diseases.
Int J Mol Sci. 2023 Mar 9;24(6):5276. doi: 10.3390/ijms24065276.
4
Pharmacogenetics of thiopurines.
Cancer Drug Resist. 2019 Jun 19;2(2):256-270. doi: 10.20517/cdr.2019.004. eCollection 2019.
5
Antileukemic Activity and Molecular Docking Study of a Polyphenolic Extract from Coriander Seeds.
Pharmaceuticals (Basel). 2021 Aug 5;14(8):770. doi: 10.3390/ph14080770.
6
Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA).
BMC Cancer. 2021 Jul 8;21(1):789. doi: 10.1186/s12885-021-08479-z.
7
Effect of PDCA-based nursing management model on the quality of life and complications of patients with acute leukemia undergoing chemotherapy.
Am J Transl Res. 2021 Apr 15;13(4):3246-3253. eCollection 2021.
8
Recent Advances in Molecular Diagnosis and Prognosis of Childhood B Cell Lineage Acute Lymphoblastic Leukemia (B-ALL).
Indian J Hematol Blood Transfus. 2021 Jan;37(1):10-20. doi: 10.1007/s12288-020-01295-8. Epub 2020 Jun 3.
9
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia.
Cancers (Basel). 2021 Jan 7;13(2):184. doi: 10.3390/cancers13020184.
10
Development of a highly sensitive method for detection of FLT3D835Y.
Biomark Res. 2020 Aug 12;8:30. doi: 10.1186/s40364-020-00210-7. eCollection 2020.
本文引用的文献
1
Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
J Hematol Oncol. 2018 Jan 22;11(1):11. doi: 10.1186/s13045-018-0554-z.
2
SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis.
Biomark Res. 2018 Jan 3;6:1. doi: 10.1186/s40364-017-0115-6. eCollection 2018.
3
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.
J Hematol Oncol. 2018 Jan 5;11(1):4. doi: 10.1186/s13045-017-0550-8.
4
Precision therapy for acute myeloid leukemia.
J Hematol Oncol. 2018 Jan 5;11(1):3. doi: 10.1186/s13045-017-0543-7.
5
Midostaurin for the treatment of adult patients with newly diagnosed acute myeloid leukemia that is FLT3 mutation-positive.
Drugs Today (Barc). 2017 Oct;53(10):531-543. doi: 10.1358/dot.2017.53.10.2717625.
6
How I treat CLL patients with ibrutinib.
Blood. 2018 Jan 25;131(4):379-386. doi: 10.1182/blood-2017-08-764712. Epub 2017 Dec 18.
7
Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity.
Toxicology. 2018 Feb 1;394:72-83. doi: 10.1016/j.tox.2017.12.005. Epub 2017 Dec 14.
8
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with mutations.
Blood. 2018 Jan 25;131(4):426-438. doi: 10.1182/blood-2017-05-786657. Epub 2017 Nov 29.
9
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients.
Biomark Res. 2017 Nov 10;5:32. doi: 10.1186/s40364-017-0112-9. eCollection 2017.
10
Incorporation of functional elements enhances the antitumor capacity of CAR T cells.
Exp Hematol Oncol. 2017 Oct 11;6:28. doi: 10.1186/s40164-017-0088-z. eCollection 2017.
Zotero 插件